Lumenis begins a New Era in the treatment of wrinkles

Introduces Aluma™ with FACES™ technology skin renewal system

February 17, 2005 - Yokneam, Israel

Yokneam, Israel, February 17, 2005 – Lumenis^â Ltd. (LUME.PK), a global manufacturer and seller of laser and light-based devices for medical, aesthetic, ophthalmic, dental and veterinary applications, will introduce at the American Academy of Dermatology meeting in New Orleans, LA,  Aluma with FACES (Functional Aspiration Controlled Electrothermal Stimulation) technology for the non-invasive treatment of wrinkles.

Upon FDA approval, the Aluma system will be available in the United States as both a stand-alone system and a module for the flagship Lumenis One™ multi-application platform, and will add a new dimension to Lumenis’ product offering.  “With Aluma, our systems and our customers will be able to treat the full range of photorejuvenation for vascular and pigmented lesions, sun damage, texture, wrinkles and photodynamic therapy (PDT),” explained Lumenis President and CEO Avner Raz. “We have been very pleased with the results of our preliminary clinical trial.”

Aluma with FACES technology is a unique entry into the market for non-ablative photorejuvenation of the skin - a rapidly expanding market.  A recent study identified effective treatment of fine lines and wrinkles as “the greatest unmet need” in rejuvenation skin care. 

“Our results with Aluma have been substantial,” notes Michael Gold, MD, a dermatologist in private practice in Nashville, TN. “The unique vacuum-assisted bipolar delivery of radio frequency energy (RF) deep into the dermal layer bypasses the epidermis, resulting in a pain-free and minimal risk procedure. We achieved 90% patient satisfaction and greater than 40% improvement of periorbital and perioral wrinkles.  This is fantastic by today’s standards.”

 

About Lumenis

Lumenis is a global developer, manufacturer and seller of laser and light-based devices for medical, aesthetic, ophthalmic, dental and veterinary applications. The Company offers a wide range of products along with extensive product support systems including training, education and service. Lumenis invests heavily in research and development to maintain and enhance its leading industry position. The Company holds numerous patents worldwide on its technologies. For more information about Lumenis and its products, log onto www.lumenis.com.

Investors:

Lauri Hanover

              1-866-232-6803 
                                         972-4-959-9122 

The statements in this press release that are not historical facts are forward-looking statements that are subject to risks and uncertainties. The Company's actual results could differ materially from those anticipated in the forward looking statements based on a variety of factors, including, among others: uncertainties with respect to market acceptance of the Company's products, the implementation and outcome of its Turnaround Plan, obtaining regulatory approvals for new products or for the sale of existing products in new markets and enforcement of intellectual property rights; risks associated with competition and competitive pricing pressures, economic conditions generally, the Company's international operations and the Company's ability to integrate its operations with those of acquired businesses; the outcome of the Securities and Exchange Commission investigation and several securities class action lawsuits to which the Company is subject and the outcome of the investigation conducted by the Audit Committee; uncertainties relating to the Company’s continuing liquidity; and other risks detailed from time to time in the reports filed by Lumenis with the SEC, including its annual report on Form 10-K and quarterly reports on Form 10-Q.

Search

| Advanced Search| Site Map| Home